(Q33860283)

29 July 2017

1 reference

title

Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation (English)

1 reference

29 July 2017

1 reference

Anderson GP

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

161

1 reference

29 July 2017

issue

3 Pt 2

1 reference

29 July 2017

page(s)

S188-96

1 reference

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Long-term cardiovascular safety of salmeterol powder pharmacotherapy in adolescent and adult patients with chronic persistent asthma: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Why are long-acting beta-adrenoceptor agonists long-acting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Beta-adrenoceptor agonists in bronchial asthma: role of k+-channel opening in mediating their bronchodilator effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Enantiomers of bronchodilating beta2-adrenoceptor agonists: is there a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Transcriptional regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Inhibition of interleukin-4 and interleukin-13 release from immunologically activated human basophils due to the actions of anti-allergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

TH2 and 'TH2-like' cells in allergy and asthma: pharmacological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Granulocyte-macrophage colony stimulating factors (GM-CSF) and interleukin 8 (IL-8) production by human bronchial epithelial cells (HBEC) in asthmatics and controls. Lack of in vitro effect of salbutamol compared to sodium nedocromil

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Type I interferons keep activated T cells alive

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Interleukin-1alpha and tumour necrosis factor-alpha modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: inhibition by dexamethasone and fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Extracellular regulation of interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Potential masking effects of salmeterol on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Abnormalities in airway smooth muscle in fatal asthma. A comparison between trachea and bronchus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Organ culture with proinflammatory cytokines reproduces impairment of the beta-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by beta-adrenoceptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Evidence for a functional interaction between calmodulin and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

Modulation of airway intraepithelial dendritic cells following exposure to steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_2.A1Q4-9

10.1164/AJRCCM.161.SUPPLEMENT_2.A1Q4-9

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference